 WALTHAM, Mass., Dec. 6, 2020 PRNewswire -- Syndax Pharmaceuticals, Inc. Syndax, the Company or we Nasdaq: SNDX, a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced updated data from the Companys Phase 1 trial of... 